The effect of APOE ε4 is different depending on disease stage of AD [111], and longitudinal tracking of the same sample can more accurately describe the changes in the influence of the APOE gene on various biomarkers, establishing a better pathological change model. The gene discussed is APOE; the disease is Alzheimer disease.